Bioventix Share News (BVXP)

Bioventix posts healthy profits, ups dividend; warns of plateauing vit-D sales

(Sharecast News) - Aim's Bioventix announced Monday it would pay a special dividend after a strong year of revenue and profit growth - but also sounded a warning over one of its key revenue streams.

Bioventix Lifts Interim Dividend 25% After Strong Revenue Growth

LONDON (Alliance News) - Medical technology company Bioventix PLC on Monday said it saw an increase in revenue and profit in the first half of its financial year, due to a by

Bioventix profits will beat forecasts, boost eyed from Siemens link

(ShareCast News) - Bioventix revealed that revenues and profits will be ahead of expectations for the full year thanks to currency effects and continued demand for its monoclonal antibodies. Revenue for the year to 30 June will come in at £5.3m, which is at least 11% ahead of the forecast £4.8m and

Bioventix Signs Antibodies Deal With Norway-Based Pre Diagnostics

Bioventix Hikes Dividend As Profit And Sales Increase In First Half

Bioventix To Take 10% Stake As It Teams Up With Norwegian Start-up

Bioventix Optimistic For Further Growth As Annual Profit Rises

LONDON BRIEFING: Bwin.Party Chooses GVC's Takeover Offer Over 888's

Bioventix Annual Profit To "Significantly" Beat Market Expectations

Bioventix Profit Up, Optimistic On Vitamin D Antibody Product

Bioventix Raises Total Dividend 66% As Full-Year Profit Rises

Bioventix signs deal to end dispute with Diasource

Bioventix, an AIM-listed company focused on the development of anti-bodies, has signed an agreement to license intellectual property owned by Belgian company Diasource ImmunoAssays. The two groups had been in dispute over one of Diasource's European patents, but said a licence agreement was "the pr

Bioventix Signs Licence Deal With DIAsource Over Test Patent